In this downloadable slideset, review metrics that determine when to initiate therapy for chronic hepatitis B, criteria for optimal drug selection, and guidance on treatment withdrawal.
Listen to this on-demand audio for expert perspective on when to consider starting or stopping therapy and what agents to use in patients with chronic hepatitis B.
In this downloadable slideset, review criteria for initiating HBV therapy, opportunities to broaden candidacy for treatment, and the potential biologic consequences of untreated infection.
Hear expert insights on the evidence for treating patients with immune-tolerant CHB and what ALT threshold should define HBV treatment candidacy in this on-demand audio commentary.
In this downloadable slideset, review gaps identified in the 2019 National Viral Hepatitis Progress Report and key actions to implement in your practice to address them. Learn how new guidance from AASLD may affect your approach.
In this on-demand audio commentary, gain expert insights on the importance of vaccination for hepatitis A and B as well as new guidance from AASLD on HCV screening and treatment.